Table 2. Characteristics of the RCTs.
Study N Age Gender Weeks Days/Week Group (N) Treatment Arterial Stiffness Outcome Pre/Post Results Effect size (d)
Au et al. (2017) 46 23
±2
Male 12 2 G1(16) CB, FB, LI cfPWV 6.4±0.7/5.7±0.6 m/s -1.07
G2(16) CB, FB, VI 6.2±0.6/5.8±0.8 m/s -0.57
G3(14) NS 5.9±0.7/6.0±0.7 m/s 0.14
Casey et al. (2007) 42 21.4
±0.6
Male/
Female
12 3 G1(24) MA, FB, VI cfPWV 6.5±0.14/6.3±0.19 m/s -1.20
G2(18) NS 6.9±0.15/7.0±0.16 m/s 0.65
Cortez-Cooper et al. (2005) 33 28.4
±1.3
Female 11 4 G1(23) CB, FB, VI cfPWV 7.91±0.88/8.33±0.96 m/s 0.46
G2(10) NS 7.24±0.83/7.80±0.66 m/s 0.75
Okamoto et al. (2015) 18 23
±1
Male/
Female
16 3 G1(9) CB, UT, VI, CT faPWV 8.71±0.31/8.55±0.35 m/s -0.48
G2(9) CB, UT, VI, PT 8.46±0.34/8.49±0.35 m/s 0.09
Clark et al. (2011) 16 24.0
±1.6
Male/
Female
4 3 G1(9) MA, LT, LI, BF faPWV 9.26±0.39/8.73±0.32 m/s -1.49
G2(7) MA, LT, VI 8.19±0.27/7.94±0.40 m/s -0.73
Fahs et al. (2014) 32 55
±7
Male/
Female
6 3 G1(16) MA, LT, LI, BF ftPWV 8.9±0.8/9.5±0.9 m/s 0.71
G2(16) MA, LT, LI 9.0±1.2/9.0±1.1 m/s 0
Raj et al. (2012) 25 68
±5
Male/
Female
16 2 G1(13) MA, FB, MI, ET ftPWV 10.8±3.7/12.1±7.4 m/s 0.22
G2(12) MA, FB, VI, CT 14.5±10.3/16.0±10.8 m/s 0.14
Yasuda et al. (2015) 17 70.0
±5.6
Male/
Female
12 2 G1(9) EB, UT, BF CAVI 8.9±1.2/9.2±1.1 m/s 0.26
G2(8) EB, UT 8.5±0.7/8.2±0.8 m/s -0.40
Yasuda et al. (2014) 19 69.4
±6.5
Male/
Female
12 2 G1(9) MA, LT, LI CAVI 9.1±1.4/9.0±0.5 m/s -0.10
G2(10) NS 8.7±0.8/8.5±0.1 m/s -0.35
Okamoto et al. (2009a) 30 20.1
±0.4
Male/
Female
10 2 G1(10) CB, UT, VI baPWV 11.21±0.40/12.66±0.54 m/s 3.05
G2(10) CB, LT, VI 11.55±0.35/11.46±0.37 m/s -0.25
G3(10) NS no data -
Nitzsche et al. (2016) 41 23.8
±2.3
Male/
Female
- - G1(10) FW, FB, LI cfPWV 5.26±0.48/5.97±0.65 m/s 1.24
G2(15) FW, FB, MI 5.45±0.40/5.87±0.37m/s 1.09
G3(16) FW, FB, VI 5.30±0.45/5.48±0.50 m/s 0.38
Kingsley et al. (2017) 52 23.0
±0.5
Male/
Female
- - G1(26) FW, FB, VI aPWV 5.3±0.7/5.8±0.7 m/s 0.71
G2(26) NS 5.4±0.7/5.3±0.6 m/s -0.15
Lefferts et al. (2015) 40 24
±4
Male/
Female
- - G1(20) FW, UT, VI aPWV 5.1±0.5/6.0±0.7 m/s 1.48
G2(20) NS 5.1±0.5/5.2±0.5 m/s 0.20
Augustine et al. (2014) 18 24
±6
Male - - G1(9) FW, UT, VI aPWV 5.4±0.5/5.6±0.5 m/s 0.40
G2(9) NS 5.6±0.7/5.5±0.6 m/s -0.16
Okamoto et al. (2014) 20 26
±5
Male/
Female
- - G1(10) FW, UT, LI AIx -5±2/-15±3 % -3.92
G2(10) NS -4±2/-5±2 % -0.50
Yoon et al. (2010) 26 20.8
±2.2
Male - - G1(13) CB, FB, MI AIx -13.4±0.8/-10.3±0.8 % 3.88
G2(13) NS -6.9±7.3/-9.4±6.0 % -0.37
FW: free wheights; CB: combined; EB: elastic bands; MA: machines; FB: full body; UT: upper train; LT: lower train; LI: low intensity; MI: moderate intensity; VI: vigorous intensity; NS: no strength; CT: continuous training; PT: periodic training; BF: blood flow restriction; ET: eccentric training; CT: concentric training; aPWV: aortic pulse wave velocity; AIx: augmentation index; cfPWV: carotid femoral pulse wave velocity; faPWV: femoral ankle pulse wave velocity; CAVI: cardio-ankle vascular index; ftPWV: femoral tibial pulse wave velocity; baPWV: brachial ankle pulse wave velocity.